Now showing 1 - 6 of 6
  • Publication
  • Publication
    Feasibility of Endoscopic Retrograde Cholangiopancreatography in Healthy Cats
    (John Wiley & Sons, Inc, 2014)
    Spillmann, Thomas
    ;
    Willard, Michael D
    ;
    ;
    Suchodolski, Jan S
    ;
    Steiner, Joerg M
    Cats are predisposed to diseases of the biliary tract and the exocrine pancreas and these can be challenging to diagnose. In humans and dogs > 10 kg, endoscopic retrograde cholangiopancreatography (ERCP) has been successfully used to diagnose some of these disorders. The purpose of our study was to determine whetherERCP would also be feasible in cats using a pediatric duodenoscope. Four purpose-bred, clinically healthy, castrated domestic shorthair cats participated in two studies. Study 1 compared standard white light endoscopy with chromoendoscopy for localizing the major duodenal papilla. In Study 2 ERCP was performed.Repeated clinical examinations and measurements of serum feline pancreatic lipase immunoreactivity (fPLI) were performed before and up to 18 hours after interventions on all cats. Chromoendoscopy was subjectively judged to be superior for localizing the major papilla. Insertion of the ERCP catheter was best accomplished when cats were in dorsal recumbency. Complete ERCP was successful in two cats. In the other cats, either retrograde cholangiography or pancreatography was possible. Serum fPLI concentrations increased temporarily in two cats during Study 2 when measured immediately, 2, 4, and 18 h after ERCP. Peak fPLI concentrations were detected either immediately after ERCP or 2 h later. No clinical signs of complications were observed within 18 h after the procedures. Findings indicated that ERCP is technically demanding but feasible in healthy cats. Future studies need to determine whether the temporary increases in serum fPLI concentrations are clinically important and to investigate the utility of ERCP in feline patients.
  • Publication
    Evaluation of endoscopically obtained duodenal biopsy samples from cats and dogs in an adapter-modified Ussing chamber
    (Korean Society of Veterinary Science, 2014) ;
    DeBiasio, John V
    ;
    Suchodolski, Jan S
    ;
    Newman, Shelley
    ;
    Musch, Mark W
    ;
    Steiner, Jorg M
    This study was conducted to evaluate an adapter-modified Ussing chamber for assessment of transport physiology in endoscopically obtained duodenal biopsies from healthy cats and dogs, as well as dogs with chronic enteropathies. 17 duodenal biopsies from five cats and 51 duodenal biopsies from 13 dogs were obtained. Samples were transferred into an adapter-modified Ussing chamber and sequentially exposed to various absorbagogues and secretagogues. Overall, 78.6% of duodenal samples obtained from cats responded to at least one compound. In duodenal biopsies obtained from dogs, the rate of overall response ranged from 87.5% (healthy individuals; n = 8), to 63.6% (animals exhibiting clinical signs of gastrointestinal disease and histopathological unremarkable duodenum; n = 15), and 32.1% (animals exhibiting clinical signs of gastrointestinal diseases and moderate to severe histopathological lesions; n = 28). Detailed information regarding the magnitude and duration of the response are provided. The adapter-modified Ussing chamber enables investigation of the absorptive and secretory capacity of endoscopically obtained duodenal biopsies from cats and dogs and has the potential to become a valuable research tool. The response of samples was correlated with histopathological findings.
  • Publication
    Development and analytical validation of a radioimmunoassay for the measurement of alpha₁-proteinase inhibitor concentrations in feces from puppies and healthy adult dogs
    (Sage Publications, Inc, 2011)
    Heilmann, Romy M
    ;
    Paddock, Casey G
    ;
    ;
    Berghoff, Nora
    ;
    Suchodolski, Jan S
    ;
    Steiner, Joerg M
    Canine α1-proteinase inhibitor (cα₁-PI), a proteolysis-resistant protein with a molecular weight similar to albumin, has been shown to be clinically useful as a marker for gastrointestinal protein loss in dogs. A competitive, liquid-phase radioimmunoassay was developed and analytically validated. Fecal samples were collected from 101 healthy pet dogs of various breeds and ages, and fecal cα₁-PI (Fcα₁-PI) concentrations were compared between dogs of different age groups. A reference interval for Fcα₁-PI concentration was calculated using the central 95th percentile. Analytical sensitivity of the assay was 2.2 μg Fcα₁-PI/g feces. Observed-to-expected ratios for the serial dilution and spiking recovery of 9 and 6 fecal extracts ranged from 90.4 to 152.0% and from 71.3 to 112.3%, respectively. Coefficients of variation for intra- and interassay variability for 6 fecal extracts were ≤10.8% and ≤12.5%, respectively. The reference intervals for the mean and maximum Fcα₁-PI from fecal samples collected on 3 consecutive days were 2.2 13.9 μg/g and 2.2-21.0 μg/g, respectively. Fcα₁-PI was significantly higher in dogs <1 year of age (P < 0.0001 for both mean and maximum Fcα₁-PI for the 3 samples). The radioimmunoassay described is sensitive, linear, precise, reproducible, and accurate for clinical use, thus allowing reliable quantification of Fcα₁-PI in clinical patients. Using this assay, a mean or a maximum Fc₁-PI for 3 sampling days of >13.9 μg/g or >21.0 μg/g, respectively, should be considered abnormal in dogs >1 year of age. Fecal cα₁ PI concentrations in dogs <1 year of age were significantly higher and should be carefully interpreted in this age group.
  • Publication
    Impacts of Ascaridia galli Infection on Health, Immunity, Productivity and Egg Quality of Free-Range Laying Hens

    Gastrointestinal nematodes such as Ascaridia galli (A. galli) are prevalent in laying hens kept in production systems with free access to outdoor areas. A pilot study was conducted to establish an infection model with A. galli which then was used in two subsequent experiments to evaluate the impacts of different levels of A. galli infection on performance, egg quality and immune status of laying hens. In an artificial infection study, laying hens were inoculated with low (250), medium (1000), and high (2500) levels of embryonated A. galli eggs/hen. In a natural infection study, hens were ranged on the areas contaminated with A. galli during the artificial infection study. In both studies, uninfected hens served as control groups.

    Infecting hens orally with 500 or 1000 embryonated A. galli eggs in multiple applications was found to be a more reliable method compared to infecting hens using a single dose. The artificial infection study showed that A. galli infection with different dose rates had no effect on feed intake, body weight, and FCR until 40 weeks of age. There was no difference in egg production at 25, 35 and 40 weeks of age. Serum and yolk antibodies against A. galli were higher at 20 weeks post infection.

    Naturally infected hens had a higher infection intensity exhibited by higher intestinal worm counts and excreta egg counts compared to the artificially infected hens. However, this higher infection intensity did not negatively affect egg production, egg mass, feed intake, FCR and egg quality during the experiment. The liver lipid content of the hens with higher A. galli burden were compared to the uninfected hens and the results showed that the infected hens had consistently lower liver lipid reserves compared to the uninfected hens.

    Across the two trials the sensitivity of the ELISA assay was 100% and 96% for serum and egg yolk samples respectively, whereas pooled excreta egg counts had sensitivity of 93%. Measurements of serum and yolk antibody levels can be helpful for the detection of current or prior A. galli infection. The practical and non-invasive method of yolk sample analysis is likely to be as informative as using serum samples to detect A. galli infection. Results of these experiments indicate that A. galli causes no production loss during the first three months of the free range laying hen's production cycle. However, production losses that might occur in the later stages of laying cycle still needs to be investigated.

  • Publication
    Adapter-modified Ussing chamber enables evaluation of endoscopically-obtained colonic biopsy samples from cats and dogs
    (Elsevier Ltd, 2012) ;
    DeBiasio, John V
    ;
    Suchodolski, Jan S
    ;
    Newman, Shelley J
    ;
    Musch, Mark W
    ;
    Steiner, Joerg M
    Adapter-modified Ussing chambers have been used for assessment of endoscopically obtained intestinal biopsies in humans. The aim of this study was to evaluate the feasibility of an adapter-modified Ussing chamber for assessment of intestinal transport physiology in endoscopically-obtained colonic biopsies from cats and dogs. Fifteen colonic biopsies from four cats and 13 colonic biopsies from four dogs were transferred into a modified Ussing chamber and sequentially exposed to several compounds. Baseline mean ± SD conductance was measured. Changes of short circuit current (Δ/sc) were observed after exposure to glucose (number of feline biopsies that responded = 0/number of canine biopsies that responded = 4), phloridzin ('n' = 0/'n' = 7), histamine ('n' = 5/'n' = 12), serotonin (n = 7/n = 12), prostaglandin (n = 5/n = 7), forskolin (n = 7/n = 7), and ouabain (n = 9/n = 7). The adapter-modified Ussing chamber studied here enables investigation of transport physiology of endoscopically-obtained colonic biopsies from companion animals. However, we observed a large variability of results, suggesting that clinical use of this method is limited.